Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia
- PMID: 7822880
- DOI: 10.1089/jir.1994.14.217
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical